Piotr Imielski

NupulseCV, Inc. operates as a medical device company that develops technology to treat patients with heart failure. Its device which requires a minimally invasive surgery provides patients an alternative to medical therapy. The firm maintains strategic and financial partnership with heart failure companies around the world. The company was founded in 2010 and is headquartered in Raleigh, NC.

Atheer, Inc. provides an augmented reality management platform for industrial enterprises. It offers enterprise grade solutions for contextual work guidance, remote collaboration, and natural interaction across glasses and mobile devices. The company was founded by Soulaiman Itani on February 14, 2012 and is headquartered in Santa Clara, CA.

iPulse Ltd. engages in the manufacture of medical and dental instruments. The company was founded on November 23, 2012 and is headquartered in Swansea, the United Kingdom.

Felicitex Therapeutics, Inc. is a pre-clinical stage oncology drug development company developing therapies against cancer and diabetes. It operates through the Felicitex Business and TraMeta segments. The Felicitex Business segment handles the design and patents of small molecules and related methods to selectively disrupt dormant cancer cells in a manner that is specific to the disease and tissue context. The TarMeta segment built a drug discovery platform for small molecule inhibitors targeting cancer. The company was founded by Maria Vilenchik and Michael Frid on May 4, 2012 and is headquartered in Natick, MA.